These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 8094183)

  • 1. Meta-analysis of the literature or of individual patient data: is there a difference?
    Stewart LA; Parmar MK
    Lancet; 1993 Feb; 341(8842):418-22. PubMed ID: 8094183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of effect estimates from a meta-analysis of summary data from published studies and from a meta-analysis using individual patient data for ovarian cancer studies.
    Steinberg KK; Smith SJ; Stroup DF; Olkin I; Lee NC; Williamson GD; Thacker SB
    Am J Epidemiol; 1997 May; 145(10):917-25. PubMed ID: 9149663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy for non-small cell lung cancer.
    Non-small Cell Lung Cancer Collaborative Group
    Cochrane Database Syst Rev; 2000; 2000(2):CD002139. PubMed ID: 10796867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant cisplatin for advanced bladder cancer.
    Advanced Bladder Cancer Overview Collaboration
    Cochrane Database Syst Rev; 2000; (2):CD001426. PubMed ID: 10796791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis.
    Lueza B; Rotolo F; Bonastre J; Pignon JP; Michiels S
    BMC Med Res Methodol; 2016 Mar; 16():37. PubMed ID: 27025706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confronting publication bias: a cohort design for meta-analysis.
    Simes RJ
    Stat Med; 1987; 6(1):11-29. PubMed ID: 3576013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analyses and overviews of randomised trials.
    Richards SM
    Blood Rev; 1995 Jun; 9(2):85-91. PubMed ID: 7580394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group.
    Aabo K; Adams M; Adnitt P; Alberts DS; Athanazziou A; Barley V; Bell DR; Bianchi U; Bolis G; Brady MF; Brodovsky HS; Bruckner H; Buyse M; Canetta R; Chylak V; Cohen CJ; Colombo N; Conte PF; Crowther D; Edmonson JH; Gennatas C; Gilbey E; Gore M; Guthrie D; Yeap BY
    Br J Cancer; 1998 Dec; 78(11):1479-87. PubMed ID: 9836481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating patient exclusion bias in meta-analysis.
    Tierney JF; Stewart LA
    Int J Epidemiol; 2005 Feb; 34(1):79-87. PubMed ID: 15561753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methodology and reporting of meta-analyses in the neurosurgical literature.
    Klimo P; Thompson CJ; Ragel BT; Boop FA
    J Neurosurg; 2014 Apr; 120(4):796-810. PubMed ID: 24460488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review of first-line chemotherapy for newly diagnosed postoperative patients with stage II, III, or IV epithelial ovarian cancer.
    Covens A; Carey M; Bryson P; Verma S; Fung Kee Fung M; Johnston M
    Gynecol Oncol; 2002 Apr; 85(1):71-80. PubMed ID: 11925123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
    Winter-Roach BA; Kitchener HC; Dickinson HO
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004706. PubMed ID: 19160239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group.
    BMJ; 1991 Oct; 303(6807):884-93. PubMed ID: 1834291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods and characteristics of published network meta-analyses using individual patient data: protocol for a scoping review.
    Veroniki AA; Soobiah C; Tricco AC; Elliott MJ; Straus SE
    BMJ Open; 2015 Apr; 5(4):e007103. PubMed ID: 25926144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can trial quality be reliably assessed from published reports of cancer trials: evaluation of risk of bias assessments in systematic reviews.
    Vale CL; Tierney JF; Burdett S
    BMJ; 2013 Apr; 346():f1798. PubMed ID: 23610376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analyses of randomised trials: when the whole is more than just the sum of the parts.
    Parmar MK; Stewart LA; Altman DG
    Br J Cancer; 1996 Aug; 74(4):496-501. PubMed ID: 8761361
    [No Abstract]   [Full Text] [Related]  

  • 17. [Adjuvant therapy in gastric cancer].
    Di Costanzo F; Gasperoni S; Brugia M
    Tumori; 2000; 86(5 Suppl 2):S14-8. PubMed ID: 11195297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding differences in results from literature-based and individual patient meta-analyses: an example from meta-analyses of observational data.
    Poppe KK; Doughty RN; Yu CM; Quintana M; Møller JE; Klein AL; Gamble GD; Dini FL; Whalley GA;
    Int J Cardiol; 2011 Apr; 148(2):209-13. PubMed ID: 19962202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence and effect of publication bias in orthopaedic meta-analyses.
    Vavken P; Dorotka R
    J Orthop Sci; 2011 Mar; 16(2):238-44. PubMed ID: 21360256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review articles and publication bias.
    Kleijnen J; Knipschild P
    Arzneimittelforschung; 1992 May; 42(5):587-91. PubMed ID: 1388359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.